Discover how ICMR's new agreements for Phase 1 clinical trials mark a milestone in India's pharmaceutical research, targeting diseases like multiple myeloma, Zika, and influenza.

‘ICMR's new agreement includes research on therapies for #multiple_myeloma, Zika virus vaccine, influenza #vaccine, and CAR-T #cell therapy for #chronic_lymphocytic_leukemia.’

The new agreements involve:





- Collaborative research on a small molecule targeting multiple myeloma
- Development of a Zika virus vaccine
- A seasonal influenza virus vaccine trial
- Advancing CAR-T cell therapy for
chronic lymphocytic leukemia
>Indian Council of Medical Research Signs Memorandum of Agreements with Industry and Academic Partners to Advance First-in-Human Phase 1 Clinical Trials
Go to source).
He emphasized that this initiative represents a milestone towards achieving affordable and accessible cutting-edge treatments, positioning India as a potential global leader in healthcare innovation.
ICMR’s Strategic Vision and Broader Results
“This collaboration reflects our commitment to advancing clinical research in India through strategic public-private partnerships,” stated Dr. Bahl highlighting the importance of establishing Phase 1 clinical trial infrastructure as a key element in fostering the development of indigenous molecules and advanced treatments.He also noted the broader impact of ICMR’s initiatives, including the Network for Phase 1 Clinical Trials, aligning with the government’s vision of a “Viksit Bharat” (Developed India).
ICMR’s Infrastructure and Network Expansion
The ICMR Network for Phase 1 Clinical Trials comprises four strategically located institutions across India. This network, supported by a Central Coordinating Unit at ICMR Headquarters in New Delhi, aims to build and enhance India’s capacity to conduct early-phase clinical trials with robust infrastructure and dedicated manpower at each site.Advertisement
The goal of ICMR's relationships with major industrial individuals is to push innovative medication development from early-phase trials to market, decrease dependence on outside funding, and eventually support the goal of universal access to high-quality, affordable healthcare.
Advertisement
- Indian Council of Medical Research Signs Memorandum of Agreements with Industry and Academic Partners to Advance First-in-Human Phase 1 Clinical Trials- (https:pib.gov.in/PressReleasePage.aspx?PRID=2054864)
Source-Medindia